Results 1 to 10 of about 6,181 (105)
Systemic anti-cancer therapy associated with the occurrence of peripheral neurotoxicity and, specifically, peripheral neuropathy. [PDF]
What's new? While the effectiveness of systemic anticancer therapy is well documented, it commonly causes severe toxicity. This study of the 467 systemic anticancer therapy agents currently approved globally for clinical and/or research purposes found that peripheral neurotoxicity is associated with 45% of classical chemotherapies, 21% of targeted ...
Higgins C +3 more
europepmc +2 more sources
Novel Active Homo-Aza (Lactam) Steroidal Antimetabolites for the Treatment of Human Pancreatic and Colorectal Cancer [PDF]
Background: Colorectal and pancreatic cancers remain therapeutically challenging, with limitations in efficacy and limitations due to toxicity from conventional antimetabolites such as 5-fluorouracil (5-FU), methotrexate (MTX), and gemcitabine (GEM ...
Konstantinos E. Alifieris +12 more
doaj +2 more sources
Subsequent pregnancies after a diagnosis of pregnancy-associated cancer. [PDF]
Approximately 1 in 15 women diagnosed with pregnancy‐associated cancer went on to have a subsequent pregnancy, with markedly higher probabilities in those diagnosed before the age of 35 and those who did not undergo antineoplastic treatments. Abstract Introduction Pregnancy‐associated cancer is a rare but clinically significant event.
Esposito G +7 more
europepmc +2 more sources
Objectives It is unclear whether the use of antineoplastic drugs for patients with lung cancer in China has changed after the implementation of the national drug price negotiation in 2016 and continual update of clinical guidelines.
Yi Liu +10 more
doaj +1 more source
Antineoplastics Encapsulated in Nanostructured Lipid Carriers
Ideally, antineoplastic treatment aims to selectively eradicate cancer cells without causing systemic toxicity. A great number of antineoplastic agents (AAs) are available nowadays, with well-defined therapeutic protocols.
Gustavo Henrique Rodrigues da Silva +6 more
doaj +1 more source
Introduction: Colorectal cancer is the most common malignancy of the digestive tract. The treatment is based basically on administering antitumor medications, like 5-fluorouracil (5-FU), which belongs to the antimetabolites, antineoplastic agents ...
Cristina Benavides Tutillo +2 more
doaj +1 more source
The Role of Chemotherapy in the Treatment of Hodgkin’s Disease
Trabalho apresentado no Simpósio Internacional sobre Doença de Hodgkin, realizado no Instituto Nacional de Câncer no Rio de Janeiro — 16 a 20 de Janeiro de 1967. Transcrição da gravação, revisto o original pelo autor.
David A. Karnofsky
doaj +1 more source
Xeloda as first-line therapy of metastatic colorectal cancer-our experience [PDF]
BACKGROUND: Results of phase III clinical studies comparing efficacy of Xeloda vs. standard 5-FU/FA protocols as first line therapy of metastatic colorectal carcinoma (MCRC), have shown better efficacy of Xeloda, with less toxic adverse effects, apart ...
Kovčin Vladimir +4 more
doaj +1 more source
Aim. Study of the pyrimidine metabolism antimetabolites that can be preformed compounds in the link of biosynthetic processes and can brake tumour’s growth is a more successful, perspective finding direction of new antitumor medications.
O. V. Welchinska
doaj +1 more source
CAQ Corner: Basic concepts of transplant immunology
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley +1 more source

